A Meet the Boss roundtable brought to you by Within3
As patients are at the heart of the healthcare industry, it is pivotal that drug developers harness their insights and improve communications when developing and marketing medicines.
That said, healthcare has been preoccupied with efforts to reduce the spread of COVID-19, which has had a knock-on effect on internal operations. What’s more, research and development comes at a high cost with uncertain return on investment, as well as elevated security and compliance concerns.
However, in the digital age patients are demanding more, and virtual engagement is high on the priority list. By exploring digital patient, healthcare professional, and KOL engagement, life sciences organisations are getting medicines to their patients faster and meeting health equity and diversity goals.
So, how can your organisation benefit from virtual patient engagement?
Join Within3 and a select group of industry peers to discuss the benefits of collaborating with patients, how virtual technology can help you achieve your key objectives and successfully run decentralised trials.
Thought Leader Luke Rogers is the Senior Director of Business Partnerships at Within3. Luke's background includes degrees in… Find out more
We host over 1000 virtual events a year with 100,000’s executives globally – all focused on helping industry leaders and disruptors solve these three key challenges, ensuring relevant discussions that connect with outcomes.
Delivering against your objectives